CERS
Price
$1.70
Change
+$0.02 (+1.19%)
Updated
Oct 4, 02:53 PM (EDT)
27 days until earnings call
MYO
Price
$3.98
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
33 days until earnings call
Ad is loading...

CERS vs MYO

Header iconCERS vs MYO Comparison
Open Charts CERS vs MYOBanner chart's image
Cerus
Price$1.70
Change+$0.02 (+1.19%)
Volume$100
CapitalizationN/A
Myomo
Price$3.98
Change-$0.00 (-0.00%)
Volume$65K
CapitalizationN/A
View a ticker or compare two or three
CERS vs MYO Comparison Chart
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MYO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CERS vs. MYO commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Buy and MYO is a StrongBuy.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (CERS: $1.68 vs. MYO: $3.98)
Brand notoriety: CERS and MYO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 60% vs. MYO: 29%
Market capitalization -- CERS: $342.62M vs. MYO: $93.15M
CERS [@Medical Specialties] is valued at $342.62M. MYO’s [@Medical Specialties] market capitalization is $93.15M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileMYO’s FA Score has 0 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • MYO’s FA Score: 0 green, 5 red.
According to our system of comparison, MYO is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 3 TA indicator(s) are bullish while MYO’s TA Score has 4 bullish TA indicator(s).

  • CERS’s TA Score: 3 bullish, 6 bearish.
  • MYO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MYO is a better buy in the short-term than CERS.

Price Growth

CERS (@Medical Specialties) experienced а -5.62% price change this week, while MYO (@Medical Specialties) price change was +7.28% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.78%. For the same industry, the average monthly price growth was +3.71%, and the average quarterly price growth was -3.88%.

Reported Earning Dates

CERS is expected to report earnings on Oct 31, 2024.

MYO is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Medical Specialties (-1.78% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CERS($343M) has a higher market cap than MYO($93.2M). MYO YTD gains are higher at: -20.559 vs. CERS (-22.222). MYO has higher annual earnings (EBITDA): -7.71M vs. CERS (-26.34M). CERS has more cash in the bank: 65.9M vs. MYO (8.87M). MYO has less debt than CERS: MYO (601K) vs CERS (96M). CERS has higher revenues than MYO: CERS (156M) vs MYO (19.2M).
CERSMYOCERS / MYO
Capitalization343M93.2M368%
EBITDA-26.34M-7.71M341%
Gain YTD-22.222-20.559108%
P/E RatioN/AN/A-
Revenue156M19.2M813%
Total Cash65.9M8.87M743%
Total Debt96M601K15,973%
FUNDAMENTALS RATINGS
CERS vs MYO: Fundamental Ratings
CERS
MYO
OUTLOOK RATING
1..100
5110
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
6336
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7548

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (51) in the Medical Specialties industry is in the same range as MYO (58) in the Medical Distributors industry. This means that CERS’s stock grew similarly to MYO’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MYO (100) in the Medical Distributors industry. This means that CERS’s stock grew similarly to MYO’s over the last 12 months.

CERS's SMR Rating (96) in the Medical Specialties industry is in the same range as MYO (98) in the Medical Distributors industry. This means that CERS’s stock grew similarly to MYO’s over the last 12 months.

MYO's Price Growth Rating (36) in the Medical Distributors industry is in the same range as CERS (63) in the Medical Specialties industry. This means that MYO’s stock grew similarly to CERS’s over the last 12 months.

MYO's P/E Growth Rating (100) in the Medical Distributors industry is in the same range as CERS (100) in the Medical Specialties industry. This means that MYO’s stock grew similarly to CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSMYO
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
CERS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MYO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPKKY9.540.10
+1.08%
Spark New Zealand Limited
ANCTF54.450.15
+0.28%
Alimentation Couche-Tard Inc.
EZOO0.62N/A
N/A
EZAGOO LTD.
TEZNY25.89-0.60
-2.25%
Terna Rete Elettrica Nazionale SPA
STEK0.04N/A
-7.85%
Stemtech Corp.

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with MASS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
-0.59%
MASS - CERS
52%
Loosely correlated
+2.65%
FLGT - CERS
50%
Loosely correlated
-2.74%
KIDS - CERS
46%
Loosely correlated
-0.89%
VCYT - CERS
44%
Loosely correlated
-2.44%
BLFS - CERS
43%
Loosely correlated
+0.16%
More

MYO and

Correlation & Price change

A.I.dvisor tells us that MYO and CTKB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYO and CTKB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYO
1D Price
Change %
MYO100%
+0.76%
CTKB - MYO
32%
Poorly correlated
-1.91%
PLSE - MYO
31%
Poorly correlated
-2.60%
MXCT - MYO
31%
Poorly correlated
-3.21%
CERS - MYO
29%
Poorly correlated
-0.59%
RDNT - MYO
28%
Poorly correlated
-2.27%
More